Recent Quotes
My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ligand Pharmaceuticals Incorporated - Common Stock (NQ:LGND)

210.01 +0.72 (+0.34%)
Streaming Delayed Price Updated: 11:32 AM EST, Nov 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 53,989
Open 209.29
Bid (Size) 210.34 (200)
Ask (Size) 211.23 (100)
Prev. Close 209.29
Today's Range 206.54 - 212.45
52wk Range 93.58 - 211.91
Shares Outstanding 16,676,532
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates
From Orchestra BioMed Holdings, Inc.
Via GlobeNewswire
EXCLUSIVE: Pelthos Secures Rights To Antimicrobial Drug, Raises $18 Million To Support Commercial Launch
Pelthos Therapeutics acquires U.S. rights to Xepi Cream and raises $18 million to fund its relaunch and expand dermatology product offerings. 
Via Benzinga

Performance

YTD
+93.7%
+93.7%
1 Month
+16.7%
+16.7%
3 Month
+42.9%
+42.9%
6 Month
+97.4%
+97.4%
1 Year
+70.1%
+70.1%

More News

Read More
Ligand (LGND) Q3 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Ligand Pharmaceuticals Soars to New Heights: A Deep Dive into its 52-Week High
Via MarketMinute
Topics Intellectual Property
Earnings Scheduled For November 6, 2025
Via Benzinga
Ligand Pharmaceuticals (NASDAQ:LGND) Surges on Strong Q3 2025 Earnings Beat and Raised Guidance
Via Chartmill
Topics Earnings
What's Next: Ligand Pharmaceuticals's Earnings Preview
Via Benzinga
Johnson & Johnson's Uninterrupted Dividend Growth: Innovation in Medicine and MedTech Drives Strong Q2 2025 Performance
Via MarketMinute
Topics Artificial Intelligence Intellectual Property
What Analysts Are Saying About Ligand Pharmaceuticals Stock
Via Benzinga
Earnings Scheduled For August 7, 2025
Via Benzinga
Earnings Scheduled For May 8, 2025
Via Benzinga
Earnings Scheduled For February 27, 2025
Via Benzinga
Ligand (LGND) Q2 Revenue Jumps 15%
Via The Motley Fool
Topics Intellectual Property
Ligand Pharmaceuticals (NASDAQ:LGND) Surpasses Q2 2025 Earnings Estimates with Strong Royalty Growth
Via Chartmill
Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed
From Orchestra BioMed Holdings, Inc.
Via GlobeNewswire
Pelthos, Ligand Gain After Launch Of First Prescription-At-Home Treatment For Water Warts
Via Stocktwits
Topics Government
Pelthos Therapeutics Launches First At-Home Prescription Gel For Highly Contagious Skin Disease
Via Benzinga
Verona Pharma, Rhythm Pharmaceuticals, AES And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Gold Falls Over 1%; D.R. Horton Posts Downbeat Earnings
Via Benzinga
Channel Therapeutics Stock Soars On Announcement Of Subsidiary’s Merger With Ligand Pharma Units: Retail’s Elated
Via Stocktwits
Dow Falls Over 1%; US Initial Jobless Claims Decline
Via Benzinga
Topics Stocks
EXCLUSIVE: Ligand Subsidiary Pelthos Therapeutics To Combine with Channel Therapeutics Creating Pain Medicines Focused Entity
Via Benzinga
Analyst Sees Big Upside In Ligand's Capital-Efficient Biotech Strategy
Via Benzinga
This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Via Benzinga
Ligand to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
From Ligand Pharmaceuticals Incorporated
Via Business Wire

Frequently Asked Questions

Is Ligand Pharmaceuticals Incorporated - Common Stock publicly traded?
Yes, Ligand Pharmaceuticals Incorporated - Common Stock is publicly traded.
What exchange does Ligand Pharmaceuticals Incorporated - Common Stock trade on?
Ligand Pharmaceuticals Incorporated - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Ligand Pharmaceuticals Incorporated - Common Stock?
The ticker symbol for Ligand Pharmaceuticals Incorporated - Common Stock is LGND on the Nasdaq Stock Market
What is the current price of Ligand Pharmaceuticals Incorporated - Common Stock?
The current price of Ligand Pharmaceuticals Incorporated - Common Stock is 210.01
When was Ligand Pharmaceuticals Incorporated - Common Stock last traded?
The last trade of Ligand Pharmaceuticals Incorporated - Common Stock was at 11/11/25 11:32 AM ET
What is the market capitalization of Ligand Pharmaceuticals Incorporated - Common Stock?
The market capitalization of Ligand Pharmaceuticals Incorporated - Common Stock is 3.50B
How many shares of Ligand Pharmaceuticals Incorporated - Common Stock are outstanding?
Ligand Pharmaceuticals Incorporated - Common Stock has 4B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.